Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

University Hospital, Lille (1)

Zhejiang Cancer Hospital (1)

Collaborator

Intervention

biopsy (1)

biospecimen collection (1)

computed tomography (1)

laboratory biomarker analysis (1)

nivolumab (1)

positron emission mammography (1)

talimogene laherparepvec (1)

without any intervention (1)

Study Documents

Intervention Type

other (2)

biological (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

signet ring cell carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)

Active, not recruiting

Gastric Cancer
Signet Ring Cell Carcinoma

Without any intervention

Hangzhou, Zhejiang, China

Cancer Hospital of the University of Chinese Academy of Sciences

Aug 2, 2023

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting

Adenoid Cystic Skin Carcinoma
+38 more

Biopsy
+6 more

Los Angeles, California
+35 more

Jan 31, 2023

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

Completed

Signet Ring Cell Carcinoma
+4 more

Lille, France

University Hospital of Lille

Dec 8, 2014